Noventra Pharma | SLU-PP-332 2mg - 2ml | Compound Peptide Pen
High-Strength Nuclear Receptor Metabolic Research Compound
SLU-PP-332 is an investigational peptide studied in scientific research exploring nuclear receptor signalling pathways, cellular energy regulation mechanisms, and mitochondrial activity-related processes within controlled laboratory environments.
It is referenced in experimental research focusing on metabolic signalling networks, receptor activation pathways, and peptide-mediated biological response systems.
Developed as a 2mg (2ml) research compound pen, this formulation is designed for precise laboratory investigation where low-dose receptor activity profiling and metabolic pathway research are of interest.
Key Benefits – Noventra Pharma SLU-PP-332 Compound Peptide Pen 2mg (2ml)
• Nuclear receptor research compound studied in metabolic signalling pathways
• Investigated in cellular energy regulation and mitochondrial research models
• Of interest in receptor activation and peptide signalling studies
• 2mg (2ml) research formulation for controlled laboratory investigation
• Studied in experimental metabolic and cellular pathway research contexts
• Pre-filled pen format designed for precise laboratory handling
• High-purity investigational formulation from Noventra Pharma
• Manufactured for stability, consistency, and research reliability
⚖️ DISCLAIMER
This product is intended strictly for laboratory research purposes only. It is not a medicine and has not been evaluated or approved by the South African Health Products Regulatory Authority (SAHPHRA) for human or animal use.
This product is supplied strictly for laboratory research purposes only and is not intended for human consumption.
Products sold on this website are not intended to diagnose, treat, cure, or prevent any disease.
By purchasing, the customer confirms they are qualified to handle and use this product in accordance with applicable laws and regulations.
